Regulon, Inc., founded in 1997 by Teni Boulikas, is a California based biotechnology company committed to the discovery, testing, and commercialization of anticancer medicines. Its research and development activities have achieved a breakthrough in the development of a series of new low toxicity anticancer pharmaceuticals based on a unique, patented, liposome encapsulation technology.